CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GALDY

Azelaic acid 15% Gel

Phase 3
Galderma Group AG/ADR (GALDY)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Papulopustular Rosacea (PPR)

View Full Landscape
Drug Information

Target Indication

Papulopustular Rosacea (PPR)

Clinical Trial

NCT01493687

Last updated: 1/23/2026

Patent & Exclusivity
ActiveRLD

Latest Patent Expiry

Feb 28, 2029(2y 6m)

Patents Listed

4

Application

NDA 207071
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.